- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA clears Elscint entry-level spiral CT
Israeli multimodality vendor Elscint received Food and Drug Administration510(k) clearance last month for SeleCT/SP, an entry-level spiralCT scanner designed for cost-conscious customers (SCAN 7/17/96).The compact scanner, which was introduced at last
Israeli multimodality vendor Elscint received Food and Drug Administration510(k) clearance last month for SeleCT/SP, an entry-level spiralCT scanner designed for cost-conscious customers (SCAN 7/17/96).The compact scanner, which was introduced at last year's RadiologicalSociety of North America meeting, uses a unique short-geometrydesign to save space. Elscint plans to begin international deliveriesof SeleCT/SP in the third quarter, with U.S. shipments startingin the fourth quarter.
In other SeleCT/SP news, Elscint signed an agreement with BirlaMedical Technologies of India in which BMT will assemble SeleCT/SPunder license for sale in the Indian market. BMT expects to beginassembling SeleCT/SP scanners in a factory near New Delhi laterthis year.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
